Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

p107 Inhibitors

The class of compounds known as p107 inhibitors constitutes a distinctive category of chemical agents that primarily target the cellular process of cell cycle regulation. These inhibitors are specifically designed to interact with and modulate the activity of the p107 protein, which is a key member of the retinoblastoma (Rb) family of tumor suppressor proteins. The p107 protein plays an integral role in regulating the progression of the cell cycle by acting as a negative regulator that prevents cell division until certain checkpoints are met. Structurally, p107 inhibitors are composed of diverse chemical moieties that enable them to bind to specific regions of the p107 protein, thereby disrupting its functional activity and influencing downstream cellular processes. Upon binding to the p107 protein, these inhibitors exert their effects through a multifaceted mechanism. They can hinder the formation of protein complexes involving p107, thereby diminishing its ability to arrest the cell cycle at specific stages. Moreover, p107 inhibitors can disrupt the interactions between p107 and other regulatory proteins, thereby perturbing the finely orchestrated signaling pathways that dictate cell cycle progression. By interfering with these intricate cellular processes, p107 inhibitors hold the potential to significantly influence cellular proliferation dynamics. Researchers have extensively investigated the structural and functional properties of p107 inhibitors, seeking to understand their precise modes of interaction with the p107 protein and the resulting implications for cellular behavior. Through these studies, a deeper comprehension of the intricate relationships between p107 and its regulatory partners has emerged, shedding light on the fundamental mechanisms governing cell cycle progression. This class of compounds continues to be an area of active research and exploration, with implications that extend beyond the realm of basic science, potentially paving the way for novel avenues of cellular manipulation in various contexts.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Gossypol

303-45-7sc-200501
sc-200501A
25 mg
100 mg
$116.00
$230.00
12
(1)

Gossypol, a polyphenolic compound, demonstrates intriguing molecular behavior through its ability to form strong π-π stacking interactions and hydrogen bonds, which enhance its binding affinity to various targets. Its unique structural features, including multiple hydroxyl groups, facilitate diverse intermolecular interactions, influencing reaction kinetics. The compound's hydrophobic regions contribute to its solubility profile, affecting its distribution in biological systems and modulating specific pathways.

Dinaciclib

779353-01-4sc-364483
sc-364483A
5 mg
25 mg
$247.00
$888.00
1
(0)

While not exclusively targeting CDK12 and CDK13, Dinaciclib is a potent CDK inhibitor that affects multiple CDKs, including CDK12 and CDKIt has been investigated for its anti-tumor effects.

Aurora Kinase/Cdk Inhibitor

443797-96-4sc-203829
5 mg
$440.00
(0)

While primarily a CDK9 inhibitor, JNJ-7706621 also affects CDK12 and CDK13 to some extent. It has been investigated in the context of cancer therapy.

RGB-286638

784210-88-4sc-507523
250 mg
$285.00
(0)

RGB-286638 is an inhibitor that targets CDK12 and has shown potential in disrupting transcriptional processes in cancer cells.

THZ1

1604810-83-4sc-507542
1 mg
$95.00
(0)

THZ1 is a covalent inhibitor of multiple CDKs, including CDK12.